Xontogeny, LLC's Net Worth

$14.7 Million

Estimate Recalculated Apr 9, 2024 07:12AM EST

Who is Xontogeny, LLC?

Xontogeny, LLC has an estimated net worth of $14.7 Million. This is based on reported shares across multiple companies, which include Landos Biopharma, Inc., and CATABASIS PHARMACEUTICALS INC.

SEC CIK

Xontogeny, LLC's CIK is 0001844296

Past Insider Trading and Trends

2021 was Xontogeny, LLC's most active year for acquiring shares with 15 total transactions. Xontogeny, LLC's most active month to acquire stocks was the month of January. 2021 was Xontogeny, LLC's most active year for disposing of shares, totalling 5 transactions. Xontogeny, LLC's most active month to dispose stocks was the month of January. 2021 saw Xontogeny, LLC paying a total of $42,678,085.97 for 14,887,092 shares, this is the most they've acquired in one year. In 2021 Xontogeny, LLC cashed out on 13,369,728 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Landos Biopharma, Inc. (LABP) Snapshot price: $5.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 27
Form 4
+3.55%
250.19K
$12.84
$3,212,445.93
7.3M
Feb 5 - Feb 9
Form 4
+167.25%
14.62M
$16.00
$20,000,000.00
23.36M
Feb 8
Form 3
—
0
—
—
0
No matching records found

CATABASIS PHARMACEUTICALS INC (ATXS) Snapshot price: $14.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found